Once corrected for hematoma architecture, type of surgery, and use of antithrombotic medication, in a multivariate regression model, preoperative use of ACE inhibitors was associated with a twofold increase in the likelihood of hematoma recurrence. The gene discussed is ACE; the disease is hematoma.